Evidence map›Paper›PMID 42368480›Full record

ArticleThe Neurohospitalist2026

Proprioceptive Stimuli as a Trigger for Leucine-Rich Glioma-Inactivated-1 (LGI1) IgG Associated Autoimmune Seizures, a Case Report.

Ashutosh Gupta, Miles D Holmes, Divyanshu Dubey, Shirin Jamal Omidi, Megan Goyal, Shitiz Sriwastava, Rajesh K Gupta

Abstract readCase Reports
In one paragraph

Article in The Neurohospitalist, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ashutosh GuptaUniversity of Texas Health Science Center, Houston, TX, USA.ORCID https://orcid.org/0000-0002-2525-9655
Miles D HolmesUniversity of Texas Health Science Center, Houston, TX, USA.
Divyanshu DubeyMayo Clinic, Rochester, MN, USA.
Shirin Jamal OmidiUniversity of Texas Health Science Center, Houston, TX, USA.
Megan GoyalUniversity of Texas Health Science Center, Houston, TX, USA.
Shitiz SriwastavaUniversity of Texas Health Science Center, Houston, TX, USA.
Rajesh K GuptaUniversity of Texas Health Science Center, Houston, TX, USA.ORCID https://orcid.org/0000-0002-4959-5477

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leucine-rich glioma-inactivated-1 (LGI1) IgG-associated autoimmune encephalitis typically presents with faciobrachial dystonic seizures, hyponatremia, and temporal lobe MRI abnormalities. However, the clinical spectrum of LGI1 IgG-associated AE extends beyond these classical features, with reports of diverse seizure semiologies and atypical presentations challenging traditional diagnostic paradigms. This study reports a male in his late 60s presenting with recurrent episodes of right foot cramping and electric shock-like pain, progressing to generalized tonic-clonic seizures. Initial workup suggested chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), but LGI1 IgG antibodies were subsequently detected. Despite treatment with intravenous immunoglobulin (IVIG), the seizures persisted. This case highlights the heterogeneity in LGI1 encephalitis presentations. The patient's proprioceptive-induced reflex seizures represent a rare manifestation of the disease. Treatment with rituximab, a B-cell depleting therapy, resulted in significant improvement, suggesting its potential effectiveness in LGI1 encephalitis with a resistant seizure course. The case also emphasizes the intricate interplay between the mesial temporal lobe, basal ganglia, and frontal regions in LGI1 encephalitis pathophysiology.

Indexed as

autoimmune seizuresLGI1proprioceptiverituximab

Identifiers

PMID42368480
PMCPMC13309356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.